Filter
23
Filtered Results: 23
Text search:
GBD
2016
Alcohol
and
Drug
Use
Collaborator
Featured
Recommendations
2
New Publications
4
Language
Document type
Studies & Reports
10
No document type
9
Guidelines
2
Manuals
1
Situation Updates
1
Countries / Regions
Global
3
Latin America and the Carribbean
2
India
2
Malawi
1
Mozambique
1
Africa
1
Asia
1
Western and Central Europe
1
South Africa
1
Ethiopia
1
Authors & Publishers
Publication Years
Category
Guidelines
2
Studies & Reports
2
Mental Health
2
Non-communicable Diseases
2
Countries
1
Clinical Guidelines
1
Policies
1
Capacity Building
1
Other
1
Age & Elderly
1
Toolboxes
Global Overview
3
Drugs
2
Substance Use Disorders, Others
2
General Studies & Reports
2
Studies & Reports
2
Substance Use Disorders & Addiction
2
Alcohol
1
HIV in Children and mental health
1
General Reports
1
Children & Adolescents
1
Children with disabilities
1
Latin America
1
Epilepsy
1
General
1
Universal Health Coverage UHC and 90-90-90 Strategy
1
Global Impact: Socio-economic, health services, TB & HIV
1
General
1
MHPSS – Psychosocial Support
1
Epilepsy
1
Mental Disorders
1
Non-communicable Diseases NCD
1
Prevention & Strategies
1
Studies & Reports
1
General
1
Neurological Disorders
1
Alzheimer's Disease & Dementia
1
Self-harm & Suicide
1
Global Burden of Disease
1
a systematic analysis for the Global Burden of Disease Study 2016.
The Lancet Published:November 01, 2018DOI:https://doi.org/10.1016/S2215-0366(18)30337-7
Lancet Public Health 2018 Published Online September 12, 2018 http://dx.doi.org/10.1016/ S2468-2667(18)30138-5
This document is based on currently available scientific evidence on treatment for drug use disorders and sets out a framework for the implementation of the Standards, in line with principles of public health care. The Standards identify major components and features of effective systems for the tre...
Disease Control Priorities, 3rdEdition: Volume 4.
Mental, neurological, and substance use disorders are common, highly disabling, and associated with significant premature mortality. The impact of these disorders on the social and economic well-beingof individuals, families, and societies is large...
This booklet provides an overview of all findings from the Global Burden of Disease 2017 study. Published in The Lancet in November 2018, GBD 2017 provides for the first time an independent estimation of population, for each of 195 countries and territories and the globe, using a standardized, repli...
The Global Status Report on Noncommunicable Diseases (NCDs) 2014 by the World Health Organization outlines the global impact of NCDs, including cardiovascular diseases, cancer, diabetes, and chronic respiratory diseases, which are responsible for a significant portion of global mortality, particular...
Results of rapid assessment
The COVID-19 pandemic has disrupted or halted critical mental health services in 93% of countries worldwide while the demand for mental health is increasing, according to a new WHO survey. The survey of 130 countries provides the first global data showing the devastating...
This report aims to improve the assessment of mental health needs in the Americas by providing an updated and nuanced picture of: (a) the disability resulting from mental, substance use, and specific neurological disorders, plus self-harm, alone and in combination with premature mortality; (b) the i...
The World Heart Federation (WHF) Roadmap series covers a large range of cardiovascular conditions. These Roadmaps identify potential roadblocks and their solutions to improve the prevention, detection and management of cardiovascular diseases and provide a generic global framework available for loca...
1-13 December 2018 | Geneva, Switzerland UNAIDS Programme Coordinating Board Issue date: 23 November 2018
UNAIDS/PCB (43)/18.32
The WHO Guidelines on risk reduction of cognitive decline and dementia provide evidence-based recommendations on lifestyle behaviours and interventions to delay or prevent cognitive decline and dementia. These WHO Guidelines are an important tool for health care providers as well as governments, pol...
While there has been real progress in addressing the burden of disease in the WHO African region, the COVID-19 pandemic has highlighted the link between health, economics and security, as the region saw decades of progress threatened, including positive trends in decreasing inequality. In the Africa...
Oxford Policy Management (OPM) - APW with UNAIDS (thru TSF)
Epilepsy: a public health imperative
recommended
This is the first global report on epilepsy summarizing the available evidence on the burden of epilepsy and the public health response required at global, regional and national levels.
The reports highlights major gaps in awareness, diagnosis, treatment, and health policies through a series of a...
Suicide is a serious public health problem surrounded by stigma, myths, and taboos. With an annual average of 81,746 suicide deaths in the period 2010–2014 and an age-adjusted suicide rate of 9.3 per 100,000 population (age-unadjusted rate of 9.6), suicide continues to be a public health problem o...
As our world changes, so too does the burden of disease. Globalisation, evolving trade and consumption patterns, and increased access to life-saving medical care are just some of the factors that have transformed the global health landscape.
Objectives Our study aimed to systematically review the literature and synthesise findings on potential associations of built environment characteristics with type 2 diabetes (T2D) in Asia.
Developmental disabilities are common. Yet, children with developmental disabilities have been neglected in health systems planning and policy provisions for health and continue to experience stigmatization, institutionalization, barriers to access health care and inequalities in health and educatio...
